Guggenheim Capital’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-48,764
| Closed | -$352K | – | 1882 |
|
|
2024
Q3 | $352K | Buy |
48,764
+12,548
| +35% | +$115K | ﹤0.01% | 1547 |
|
|
2024
Q2 | $393K | Buy |
36,216
+5,775
| +19% | +$74K | ﹤0.01% | 1538 |
|
|
2024
Q1 | $570K | Buy |
30,441
+784
| +3% | +$18.1K | ﹤0.01% | 1422 |
|
|
2023
Q4 | $643K | Buy |
+29,657
| New | +$588K | ﹤0.01% | 1348 |
|
|
2022
Q4 | – | Sell |
-11,674
| Closed | -$457K | – | 1976 |
|
|
2022
Q3 | $457K | Sell |
11,674
-629
| -5% | -$24.3K | ﹤0.01% | 1512 |
|
|
2022
Q2 | $397K | Buy |
12,303
+284
| +2% | +$9.52K | ﹤0.01% | 1668 |
|
|
2022
Q1 | $398K | Buy |
12,019
+43
| +0.4% | +$1.62K | ﹤0.01% | 1763 |
|
|
2021
Q4 | $509K | Sell |
11,976
-41,018
| -77% | -$1.72M | ﹤0.01% | 1685 |
|
|
2021
Q3 | $2.35M | Buy |
52,994
+10,641
| +25% | +$488K | 0.01% | 977 |
|
|
2021
Q2 | $2.41M | Buy |
42,353
+4,119
| +11% | +$291K | 0.01% | 990 |
|
|
2021
Q1 | $2.86M | Buy |
38,234
+5,789
| +18% | +$475K | 0.02% | 850 |
|
|
2020
Q4 | $2.81M | Buy |
32,445
+8,358
| +35% | +$616K | 0.02% | 821 |
|
|
2020
Q3 | $1.47M | Hold |
24,087
| – | – | 0.01% | 1028 |
|
|
2020
Q2 | $1M | Hold |
24,087
| – | – | 0.01% | 1190 |
|
|
2020
Q1 | $692K | Hold |
24,087
| – | – | 0.01% | 1255 |
|
|
2019
Q4 | $1.74M | Hold |
24,087
| – | – | 0.01% | 1096 |
|
|
2019
Q3 | $3.38M | Sell |
24,087
-1,393
| -5% | -$233K | 0.03% | 787 |
|
|
2019
Q2 | $4.67M | Sell |
25,480
-6,531
| -20% | -$1.11M | 0.04% | 646 |
|
|
2019
Q1 | $5.09M | Sell |
32,011
-5,432
| -15% | -$787K | 0.04% | 601 |
|
|
2018
Q4 | $3.59M | Buy |
37,443
+4,093
| +12% | +$468K | 0.03% | 741 |
|
|
2018
Q3 | $4.71M | Buy |
33,350
+1,310
| +4% | +$202K | 0.03% | 753 |
|
|
2018
Q2 | $5.01M | Sell |
32,040
-6,298
| -16% | -$989K | 0.03% | 722 |
|
|
2018
Q1 | $6.17M | Buy |
38,338
+133
| +0.3% | +$22.6K | 0.02% | 892 |
|
|
2017
Q4 | $6.29M | Sell |
38,205
-45,883
| -55% | -$4.45M | 0.01% | 916 |
|
|
2017
Q3 | $5.24M | Buy |
84,088
+26,559
| +46% | +$2.09M | 0.01% | 1037 |
|
|
2017
Q2 | $4.58M | Sell |
57,529
-8,698
| -13% | -$629K | 0.01% | 1070 |
|
|
2017
Q1 | $4.71M | Sell |
66,227
-13,783
| -17% | -$807K | 0.01% | 1061 |
|
|
2016
Q4 | $4.08M | Buy |
80,010
+19,501
| +32% | +$919K | 0.01% | 1123 |
|
|
2016
Q3 | $2.79M | Buy |
+60,509
| New | +$2.46M | 0.01% | 1383 |
|
|
2016
Q2 | – | Sell |
-69,028
| Closed | -$2.21M | – | 2923 |
|
|
2016
Q1 | $2.21M | Sell |
69,028
-132
| -0.2% | -$4.65K | 0.01% | 1495 |
|
|
2015
Q4 | $4.03M | Sell |
69,160
-35,003
| -34% | -$1.73M | 0.01% | 1129 |
|
|
2015
Q3 | $4.41M | Buy |
104,163
+73,722
| +242% | +$4.54M | 0.01% | 1108 |
|
|
2015
Q2 | $2.22M | Buy |
+30,441
| New | +$1.96M | 0.01% | 1682 |
|
Other funds holding SAGE
BG
CP
RI
BFM